Back to Results
First PageMeta Content
Pharmacology / Biology / Micafungin / Antifungal medication / Astellas Pharma / Food and Drug Administration / Antifungal / Antifungals / Echinocandins / Pharmaceutical sciences


4-7, Doshomachi 3-chome, Chuo-ku, Osaka[removed], Japan Telephone : [removed]Facsimile : [removed]URL http://www.fujisawa.co.jp/ E-mail : [removed] February 25, 2003
Add to Reading List

Document Date: 2008-12-10 01:07:49


Open Document

File Size: 191,38 KB

Share Result on Facebook

City

Osaka / /

Company

Fujisawa Healthcare Inc. / Fujisawa GmbH / Pharmaceutical Co. Ltd. / /

Continent

Europe / /

Country

Japan / United States / Canada / /

/

Event

FDA Phase / /

IndustryTerm

owned subsidiary / /

MedicalCondition

deep-seated fungal infections / /

Organization

FDA / /

Person

Yukio Shimonaka / /

/

Position

Director Corporate Communications Fujisawa Submits Application for Marketing Authorization / /

Product

antifungal / /

URL

http /

SocialTag